- Home
- TGTX vs YOU Comparison
TGTX vs YOU Comparison
Compare TGTX & YOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGTX
- YOU
- Stock Information
- Founded
- TGTX 1993
- YOU 2010
- Country
- TGTX United States
- YOU United States
- Employees
- TGTX N/A
- YOU N/A
- Industry
- TGTX Biotechnology: Pharmaceutical Preparations
- YOU Computer Software: Prepackaged Software
- Sector
- TGTX Health Care
- YOU Technology
- Exchange
- TGTX Nasdaq
- YOU Nasdaq
- Market Cap
- TGTX 4.2B
- YOU 3.5B
- IPO Year
- TGTX 1995
- YOU 2021
- Fundamental
- Price
- TGTX $33.09
- YOU $37.85
- Analyst Decision
- TGTX Strong Buy
- YOU Buy
- Analyst Count
- TGTX 4
- YOU 6
- Target Price
- TGTX $42.50
- YOU $36.17
- AVG Volume (30 Days)
- TGTX 2.0M
- YOU 1.6M
- Earning Date
- TGTX 11-03-2025
- YOU 11-06-2025
- Dividend Yield
- TGTX N/A
- YOU 2.03%
- EPS Growth
- TGTX N/A
- YOU 105.20
- EPS
- TGTX 0.36
- YOU 1.59
- Revenue
- TGTX $454,069,000.00
- YOU $835,529,000.00
- Revenue This Year
- TGTX $82.58
- YOU $16.29
- Revenue Next Year
- TGTX $44.99
- YOU $11.01
- P/E Ratio
- TGTX $88.20
- YOU $23.80
- Revenue Growth
- TGTX 30.96
- YOU 19.85
- 52 Week Low
- TGTX $21.16
- YOU $21.67
- 52 Week High
- TGTX $46.48
- YOU $38.88
- Technical
- Relative Strength Index (RSI)
- TGTX 54.72
- YOU 69.51
- Support Level
- TGTX $31.34
- YOU $33.72
- Resistance Level
- TGTX $32.56
- YOU $38.80
- Average True Range (ATR)
- TGTX 1.03
- YOU 1.07
- MACD
- TGTX -1.33
- YOU 0.00
- Stochastic Oscillator
- TGTX 99.06
- YOU 81.32
About TGTX TG Therapeutics Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.